JPRN-UMIN000016552尚未招募未知
The influence of administration of epoetin beta pegol (CERA) and saccharated ferric oxide on erythroferron and hepcidin of hemodialyzed patients - CERA and erythroferron, hepcidin
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Inflammation, iron excess, malignancy and gastro-intestinal, hepatic, and bone marrow diseases
研究者
相似试验
已完成
不适用
The Relationship between the dose of Epoetin Beta Pegol for treatment of renal anemia and renal prognosis in CKD Patientsrenal anemia in CKD patients not on hemodialysisJPRN-UMIN000011237Toda Central General Hospital50
已完成
不适用
A study on treatment switch to epoetin beta pegol in patients who do not respond well to erythropoietin preparatioRenal anemia in Hemodialysis patientsJPRN-UMIN000008091Faculty of medicine, University of Miyazaki5
已完成
不适用
Effect of the number of epoetin alpha injections on the hemoglobin level of anaemic patients eligible for elective orthopedic surgeryanemiaNL-OMON45498Sint Maartenskliniek45
已完成
不适用
Effect of epoetin beta pegol treatment on renal anemia and blood pressure control in non-dialytic CKD patientsnon-dyalitic chronic kidney disease (CKD)JPRN-UMIN000009449Kurashiki Central Hospital100
未知
Unknown
Administration study for Epoetin Beta Pegol product to healthy Japanese adult malesot applicableJPRN-jRCT1080221926Mitsubishi chemical Medience Corporation3